An exploratory study of FDA new drug review times, Prescription Drug User Fee Acts, and R&D spending
Year of publication: |
2009
|
---|---|
Authors: | Vernon, John A. ; Golec, Joseph ; Lutter, Randall W. ; Nardinelli, Clark |
Published in: |
The quarterly review of economics and finance : journal of the Midwest Economics Association ; journal of the Midwest Finance Association. - Amsterdam [u.a.] : Elsevier, ISSN 1062-9769, ZDB-ID 1114217-0. - Vol. 49.2009, 4, p. 1260-1274
|
Subject: | Arzneimittel | Pharmaceuticals | Aufsichtsbehörde | Regulatory agency | Industrieforschung | Industrial research | Forschungskosten | Research expenditure | USA | United States | 1990-1999 |
-
Patents and R&D expenditure effects on equity returns in pharmaceutical industry
Feyzrakhmanova, Martina, (2016)
-
Generic Utilization Rates, Real Pharmaceutical Prices, and Research and Development Expenditures
Cook, Joseph P., (2010)
-
Generic Utilization Rates, Real Pharmaceutical Prices, and Research and Development Expenditures
Cook, Joseph P., (2013)
- More ...
-
Black Box Warnings and Drug Safety : Examining the Determinants and Timing of FDA Warning Labels
Begosh, Allan, (2006)
-
BLACK BOX WARNINGS AND DRUG SAFETY: EXAMINING THE DETERMINANTS AND TIMING OF FDA WARNING LABELS
Begosh, Allan, (2006)
-
Black Box Warnings and Drug Safety: Examining the Determinants and Timing of FDA Warning Labels
Begosh, Allan, (2006)
- More ...